Hamburg, Germany

Sabine Fleischer

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Topas Therapeutics Gmbh. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sabine Fleischer. Retrieved from https://idiyas.com/inventor/sabine-fleischer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sabine Fleischer: Innovator in Nanoparticle Technology

Introduction

Sabine Fleischer is a prominent inventor based in Hamburg, Germany. She has made significant contributions to the field of nanoparticle technology, particularly in the development of innovative solutions for medical applications. Her work focuses on creating nanoparticles that can induce tolerance to various therapeutic compounds and allergens.

Latest Patents

Sabine Fleischer holds a patent for "Nanoparticles comprising peptides including an n-terminal linker." This invention provides nanoparticles that can be used in compositions for inducing tolerance to therapeutic compounds, allergens, and autoantigens. The technology has potential applications in treating allergies, autoimmune diseases, and food intolerances.

Career Highlights

Fleischer is associated with Topas Therapeutics GmbH, where she continues to advance her research and development efforts. Her work has garnered attention for its innovative approach to addressing complex medical challenges through nanoparticle technology.

Collaborations

Some of her notable coworkers include Johannes Pohlner and Reinaldo Digigow, who contribute to the collaborative environment at Topas Therapeutics GmbH.

Conclusion

Sabine Fleischer's contributions to nanoparticle technology exemplify the impact of innovative thinking in the medical field. Her patent and ongoing research hold promise for improving treatment options for various health conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…